跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JUNALOX naloxone hydrochloride (as dihydrate) 400 micrograms/1 mL solution for injection, ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
JUNALOX naloxone hydrochloride (as dihydrate) 400 micrograms/1 mL solution for injection, ampoule
Approved
STANDARD
JUNALOX naloxone hydrochloride (as dihydrate) 400 micrograms/1 mL solution for injection, ampoule
Juno Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
03d89ea70066b907
Company
Juno Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
03d89ea70066b907
Product Name
JUNALOX naloxone hydrochloride (as dihydrate) 400 micrograms/1 mL solution for injection, ampoule
Artg Id
236004
Artg Name
JUNALOX naloxone hydrochloride (as dihydrate) 400 micrograms/1 mL solution for injection, ampoule
Sponsor
Juno Pharmaceuticals Pty Ltd
Company Detail Path
/organization/juno-pharmaceuticals-pty-ltd
Artg Date
2016-03-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
03d89ea70066b907
Type
Standard
Back to TGA Approvals
